Structure- and Ligand-Based Virtual Screening for Identification of Novel TRPV4 Antagonists
Transient receptor potential vanilloid (TRPV) 4 is involved in signaling pathways specifically mediating pain and inflammation, making it a promising target for the treatment of various painful and inflammatory conditions. However, only one drug candidate targeting TRPV4 has entered the clinical tri...
Saved in:
Main Authors: | Atefeh Saadabadi, Linda Wilkman, Marja Rantanen, Ari-Pekka Koivisto, Outi M. H. Salo-Ahen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/30/1/100 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
dyphAI dynamic pharmacophore modeling with AI: a tool for efficient screening of new acetylcholinesterase inhibitors
by: Yasser Hayek-Orduz, et al.
Published: (2025-02-01) -
Towards the discovery of molecules with anti-COVID-19 activity: Relationships between screening and docking results
by: Dmytro Anokhin, et al.
Published: (2024-06-01) -
The role of TASK-1 and TRPV1 channels in the male reproductive system
by: Dawon Kang, et al.
Published: (2024-12-01) -
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA1
by: David A. Close, et al.
Published: (2025-01-01) -
Linking machine learning and biophysical structural features in drug discovery
by: Armin Ahmadi, et al.
Published: (2025-01-01)